Business
Pharmacists at CVS and Walgreens Plan Three-Day Walkout, Demand Improved Working Conditions
Thousands of employees at CVS Health Corp and Walgreens Boots Alliance’s US pharmacies are gearing up for a three-day walkout set to commence on Monday,...
PaxMedica Implements 1-for-17 Reverse Stock Split, Trading on Split-Adjusted Basis to Begin Oct 31, Stock Tumbles
In a strategic move to restructure its common stock, clinical stage biopharmaceutical company PaxMedica announced today the successful execution of a 1-for-17 reverse stock split....
FOXO Technologies Unveils Groundbreaking Personalized Health Offering in Collaboration with KR8.ai
FOXO Technologies Inc has unveiled ambitious plans to launch a groundbreaking subscription-based, direct-to-consumer product offering that aims to revolutionize the health and wellness industry. FOXO,...
Motus GI Holdings Stock Surges After FDA Clearance for Pure-Vu EVS Gastro and Gen 4 Colon System
Motus GI Holdings, a leading medical technology company, continues its remarkable stock surge following the recent announcement of receiving clearance from the U.S. Food and...
Trio Petroleum Stock Soars as Company Secures Lucrative Gas Prospect
California-based oil and gas enterprise, Trio Petroleum Corp, has witnessed a remarkable surge in its stock market performance, following a groundbreaking announcement last week. The...
Safety Shot Announces Groundbreaking Direct-to-Consumer Launch of Innovative Beverage
In a groundbreaking announcement, Safety Shot Inc has unveiled plans for the direct-to-consumer launch of “Safety Shot,” a patented beverage set to revolutionize post-drinking recovery....
LumiraDx Limited Faces Delisting from Nasdaq Global Market
LumiraDx Limited, a prominent player in the healthcare technology sector, received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC on...
McDonald’s Beats Earnings Estimates in Q3 on Soaring Sales
In a remarkable display of strength, McDonald’s (MCD) has exceeded earnings expectations for the third quarter (Q3), bolstered by increased menu prices that drove sales...
Alzamend Neuro Approves Reverse Stock Split to Maintain Nasdaq Listing – Shares Decline
Alzamend Neuro, a clinical-stage biopharmaceutical company dedicated to advancing innovative treatments for Alzheimer’s disease, bipolar disorder, major depressive disorder, and PTSD, announced today that its...
CommScope Holding Reports Preliminary Q3 2023 Results; Sees Stock Decline
Global network connectivity solutions leader CommScope Holding Company has released preliminary financial results for the quarter (Q3) ending September 30, 2023, indicating a significant downturn...
